Core Scientific, Inc.
CORZ
$14.73
-$0.43-2.84%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 46.04% | 31.25% | |||
| Total Other Revenue | -7.99% | -7.08% | |||
| Total Revenue | 3.15% | -1.13% | |||
| Cost of Revenue | 4.88% | 3.21% | |||
| Gross Profit | -22.29% | -38.82% | |||
| SG&A Expenses | 12.13% | 41.94% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 63.23% | -378.79% | |||
| Total Operating Expenses | 29.12% | -17.50% | |||
| Operating Income | -121.47% | 48.07% | |||
| Income Before Tax | 84.36% | -261.24% | |||
| Income Tax Expenses | -20.89% | -22.93% | |||
| Earnings from Continuing Operations | 84.34% | -261.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 84.34% | -261.32% | |||
| EBIT | -121.47% | 48.07% | |||
| EBITDA | -871.33% | 85.29% | |||
| EPS Basic | 45.11% | -394.72% | |||
| Normalized Basic EPS | 86.80% | -258.80% | |||
| EPS Diluted | 45.36% | -396.95% | |||
| Normalized Diluted EPS | 86.80% | -258.80% | |||
| Average Basic Shares Outstanding | 0.18% | 0.88% | |||
| Average Diluted Shares Outstanding | 0.18% | 0.88% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||